代用骨移植片:企業と競争環境...市場調査レポートについてご紹介

【英文タイトル】MediPoint: Bone Grafts and Substitutes - Current and Future Players

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
代用骨移植片:企業と競争環境 (Code:GDATA403163577)

【レポートの概要(一部)】

MediPoint: Bone Grafts and Substitutes – Current and Future Players

Summary

Although autograft is still perceived as the gold-standard material in bone grafting, the wide array of alternatives available in the market has resulted in a gradual shift towards increased adoption of bone grafts and substitutes (BGS), especially in the US and European markets. In contrast to the general picture in developed countries, autograft bone still represents the most popular option during bone grafting in the Asia-Pacific (APAC) region and South America.

The report identifies and analyzes the key companies shaping and driving the global BGS market. The report provides insight into the competitive BGS landscape, including new companies entering the market and pipeline products in development. This report is built using data and information sourced from proprietary databases, secondary sources and primary research interviews and survey with leading cardiologists, with in-house analysis conducted by GlobalData’s team of industry experts.

Scope

– Investigation of current and future market competition for BGS.
– Competitor assessment including device approval analysis.
– Coverage of key market players and company profiles including business description, financial overview and SWOT analysis.
– Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis.
– Direct quotes from Key Opinion Leaders (KOL) as well as cardiologists using BGS devices in clinical practice.

Reasons to buy

– Gain a high level view of the trends shaping and driving the BGS market for coronary applications and peripheral applications in the lower extremity._x000D_
– Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition._x000D_
– Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape_x000D_
– Take a comprehensive look at the market’s device pipeline and identify promising, paradigm-shifting products._x000D_
– Create an effective counter-strategy to gain a competitive advantage against those currently in the market

.....

【日本語概要(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポートの目次(一部)】

1 Table of Contents
1 Table of Contents 2
1.1 List of Tables 5
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 11
2.2 Related Reports 12
3 Clinical Outcomes 13
3.1 Overview 13
3.2 Autograft Bone 14
3.3 Allograft Bone 15
3.4 Bone Graft Substitutes 17
3.4.1 BMPs/Growth Factors 17
3.4.2 DBMs 19
3.4.3 Synthetic Bone Substitutes 20
3.4.4 Cell-Based Matrices 22
4 Competitive Assessment 23
4.1 Overview 23
4.2 Marketed Products 23
4.2.1 Advanced Biologics 23
4.2.2 AlloSource 24
4.2.3 Bacterin 26
4.2.4 Baxter 28
4.2.5 Biomet 29
4.2.6 DePuy Synthes 32
4.2.7 Exactech 34
4.2.8 Integra LifeSciences 36
4.2.9 Medtronic 38
4.2.10 Musculoskeletal Transplant Foundation (MTF) 41
4.2.11 NuVasive 42
4.2.12 Olympus Biotech 44
4.2.13 Orthofix 46
4.2.14 RTI Surgical 48
4.2.15 Stryker 50
4.2.16 Wright Medical 52
4.2.17 Zimmer 54
5 Pipeline Products 56
5.1 Overview 56
5.2 Advanced Biologics’ OsteoMEM 56
5.3 Aursos’ Synthetic Bone Substitute 57
5.4 BioSET’s AMPLEX 57
5.5 CeraPedics’ i-FACTOR 57
5.6 NuVasive’s AttraX 57
5.7 Osiris Therapeutics’ OvationOS 58
5.8 Wright Medical’ Augment Bone Graft 58
6 Clinical Trials to Watch 59
6.1 Yale’s Review of Medtronic’s INFUSE Bone Graft 59
6.2 Wright Medical’s Augment Bone Graft 60
6.3 Orthofix’s Trinity Evolution 60
6.4 AlloSource’s AlloStem 61
6.5 NuVasive’s AttraX 62
6.6 CeraPedics’ i-FACTOR 62
6.7 BioSET’s AMPLEX 63
7 Current and Future Players 64
7.1 Trends in Corporate Strategy 64
7.2 Company Profiles 65
7.2.1 Alphatec Spine 65
7.2.2 AlloSource 67
7.2.3 Bacterin 69
7.2.4 Biomet 71
7.2.5 DePuy Synthes 73
7.2.6 Exactech 75
7.2.7 Globus Medical 76
7.2.8 Integra LifeSciences 78
7.2.9 Medtronic 80
7.2.10 NuVasive 83
7.2.11 Olympus Biotech 85
7.2.12 Orthofix 86
7.2.13 RTI Surgical 88
7.2.14 Stryker 90
7.2.15 Wright Medical 92
7.2.16 Zimmer Holdings 94
7.3 Other Players 97
8 Appendix 100
8.1 Abbreviations 100
8.2 Bibliography 103
8.3 Report Methodology 112
8.3.1 Overview 112
8.3.2 Coverage 112
8.3.3 Secondary Research 112
8.3.4 Forecasting Methodology 113
8.3.5 Primary Research – Key Opinion Leader Interviews 114
8.3.6 Expert Panel Validation 115
8.4 Physicians and Specialists Included in this Study 116
8.5 About the Authors 119
8.5.1 Analysts 119
8.5.2 Bonnie Bain, Ph.D., Global Head of Healthcare 120
8.6 About MediPoint 121
8.7 About GlobalData 121
8.8 Disclaimer 121

.....

【日本語目次(※自動翻訳出力)】

※以下は、Microsoft社の翻訳システムを使用した自動翻訳結果です。レイアウト崩れと不自然な日本語表現が多く表示されます。

。。。(後略)

【レポート販売概要】

■ タイトル:代用骨移植片:企業と競争環境
■ 英文:MediPoint: Bone Grafts and Substitutes - Current and Future Players
■ 発行日:2014年1月31日
■ 調査会社:GlobalData
■ 商品コード:GDATA403163577
■ 調査対象地域:グローバル

▼当市場調査レポートの詳細内容確認、お問い合わせ及びご購入申込は下記ページでお願いします。▼
代用骨移植片:企業と競争環境 (MediPoint: Bone Grafts and Substitutes - Current and Future Players / GDATA403163577)

※当サイトは世界の市場調査レポート紹介サイトです。市場規模、市場動向、市場予測など、多様な分析データを含むグローバル調査レポートをご案内致します。日本国内を含むアジア太平洋、中国、ヨーロッパ、アメリカ、北米、中南米、中東、アフリカ地域などにおける、製品、サービス、技術、企業(メーカー、ベンダー)、市場シェア、市場環境など多様な項目に対応致します。当サイトでご紹介するレポートは「市場調査レポート販売サイトのMarketReport.jp」でお問い合わせ及びご購入可能です。